Measurement of prostaglandin E2 and leukotriene B4 in the gingival crevicular fluid.
The arachidonic acid metabolites prostaglandin E2 (PGE2) and leukotriene B4 (LTB4) are inflammatory mediators which are likely to be involved in the pathogenesis of periodontal disease. PGE2 mediates vasodilatation, increases vascular permeability, enhances pain perception by bradykinin and histamine, alters connective tissue metabolism and enhances osteoclastic bone resorption. LTB4 causes the accumulation of inflammatory cells in the inflamed sites, and degranulation of polymorphonuclear leukocytes.


OBJECTIVE
To measure gingival crevicular fluid (GCF) levels of PGE2, LTB4 and periodontal health.


METHODS
The periodontal condition of 24 subjects was evaluated on the basis of plaque index, gingival index, probing depth, and attachment level. GCF samples were collected from one or two site(s) of each sextant per subject and the volume was measured using Periotron 6000. Samples were then assayed for PGE2 and LTB4 using a competitive enzyme immunoassay. Mean PGE2 and LTB4 levels were determined for each subject and group means compared.


RESULTS
Significant differences in the levels of PGE2 and LTB4 were found between patients with periodontitis, and non-periodontitis individuals (P < 0.001). The PGE2/LTB4 levels were positively correlated with the clinical parameters (P < 0.01) and reduced markedly after phase 1 of the periodontal treatment (P < 0.01). The total amount and concentration (ng ml-1) of LTB4 was positively correlated with the gingival index (P < 0.01).


CONCLUSIONS
These results indicate that the levels of PGE2 correlated with the severity of the periodontal status, and the levels of LTB4 correlated with gingival inflammation. Thus, our data suggest that the total amounts of PGE2/LTB4 may be good indicators for periodontal inflammation.
Tsai
C C
CC
School of Dentistry, Kaohsiung Medical College, Taiwan.
Hong
Y C
YC
Chen
C C
CC
Wu
Y M
YM
D000328:Adult; D016301:Alveolar Bone Loss / Q000378:metabolism / Q000473:pathology; D003773:Dental Plaque / Q000517:prevention & control; D003774:Dental Plaque Index; D012534:Dental Scaling; D015232:Dinoprostone / Q000032:analysis* / Q000378:metabolism / Q000502:physiology; D005260:Female; D005883:Gingival Crevicular Fluid / Q000737:chemistry*; D005891:Gingivitis / Q000378:metabolism / Q000473:pathology; D006801:Humans; D007124:Immunoenzyme Techniques; D018836:Inflammation Mediators / Q000032:analysis*; D007975:Leukotriene B4 / Q000032:analysis* / Q000378:metabolism / Q000502:physiology; D008297:Male; D008875:Middle Aged; D017622:Periodontal Attachment Loss / Q000378:metabolism / Q000473:pathology; D010512:Periodontal Index; D010514:Periodontal Pocket / Q000378:metabolism / Q000473:pathology; D010518:Periodontitis / Q000209:etiology / Q000378:metabolism / Q000628:therapy; D010519:Periodontium / Q000378:metabolism; D012044:Regression Analysis; D016745:Root Planing; D013357:Subgingival Curettage
D018836:Inflammation Mediators; D007975:Leukotriene B4; D015232:Dinoprostone